Accord Healthcare AG

Accord Healthcare AG is a Generics company based in Bottmingen (Basel-Landschaft) recorded by Swissmedic as the authorisation holder for 65 human medicines. That places it 20 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.

Key facts

Sector	Generics
City	Bottmingen
Canton	Basel-Landschaft
Authorisation holder	Yes
Medicines	65
Founded	Not available
Employees	11-50
Parent group	Intas Pharmaceuticals
Activity	Not available
Website	accord-healthcare.ch

Medicines authorised in Switzerland

Accord Healthcare AG is recorded by Swissmedic as the authorisation holder for 65 human medicines. The table shows 48 of them with product code and dispensing category.

Portfolio by product code

Synthetika55
Biotechnologika10

Portfolio by dispensing category

48 of 65 authorisations

Name	Authorisation number	Dispensing category	ATC	First authorised
Abirateron Accord 500 mg	67950	B	L02BX03	2022-01-14
Accofil 300mcg/0.5ml	66715	A	L03AA02	2019-05-27
Aciclovir Accord 250 mg / 10 ml	68384	A	-	2021-09-30
Anidulafungin Accord 100 mg	68357	A	J02AX06	2021-11-18
Apremilast Accord 10 mg	70300	B	L04AA32	2026-01-21
Azacitidin Accord 100 mg	66770	A	L01BC07	2018-11-28
Bendamustin Accord 25 mg	67461	A	L01AA09	2019-07-25
Bendamustin Accord liquid 100 mg/4 ml	68870	A	-	2022-12-15
Bortezomib Accord 1 mg	67481	A	L01XG01	2020-03-06
Bortezomib Accord liquid 2.5 mg/1 ml	68276	A	L01XG01	2021-10-21
Bupropion Accord XR 150 mg	69559	B	N06AX12	2024-09-18
Cabazitaxel Accord 60 mg/3 ml	68299	A	L01CD04	2021-07-15
Capecitabin Accord 150 mg	66982	A	L01BC06	2019-07-25
Carboplatin Accord 50 mg/5 ml	66717	A	L01XA02	2018-06-11
Cisplatin Accord 10 mg/10 ml	66809	A	L01XA01	2018-06-29
Cytarabin Accord 40 mg/2 ml	66857	A	-	2019-07-16
Daptomycin Accord 350 mg	67273	A	J01XX09	2020-02-13
Dasatinib Accord 20 mg	69965	A	L01EA02	2025-01-20
Decitabin Accord 50 mg	68255	A	L01BC08	2022-10-19
Deferasirox Accord 90 mg	67517	B	V03AC03	2021-02-01
Dimethylfumarat Accord 120 mg	69466	B	L04AX07	2024-08-08
Docetaxel Accord 20 mg/1 ml	66815	A	L01CD02	2019-08-26
Doxorubicin Accord 10 mg/5 ml	68746	A	L01DB01	2022-07-14
Doxorubicin Accord liposomal 20 mg/10 ml	68961	A	L01DB01	2025-01-09
Eltrombopag Accord 12.5 mg	69990	A	B02BX05	2025-01-14
Fingolimod Accord 0.5 mg	68377	B	-	2021-11-22
Fludarabin Accord 25 mg/ml	66750	A	L01BB05	2018-08-15
Fluorouracil Accord 250 mg/5 ml	66825	A	L01BC02	2018-08-15
Fulvestrant Accord 250 mg/5 ml	67565	B	L02BA03	2020-08-11
Gemcitabin Accord 200 mg/2 ml	66735	A	L01BC05	2018-08-20
Hetronifly 100 mg/10 ml	69906	A	L01FF12	2025-11-27
Imatinib Accord 100 mg	67097	A	L01EA01	2019-06-13
Imuldosa 130 mg / 26 ml	70225	B	L04AC05	2025-11-14
Imuldosa 45 mg/0	70224	B	L04AC05	2025-11-14
Irinotecan Accord 40 mg/2 ml	66766	A	L01CE02	2018-09-24
Jubereq 120 mg/1.7 ml	70094	A	M05BX04	2026-04-29
Lenalidomid Accord 2.5 mg	67714	A	L04AX04	2021-01-15
Letrozol Accord 2	68655	B	L02BG04	2023-10-24
Methotrexat Accord 7.5 mg/0.15 ml	66780	A	L04AX03	2018-04-13
Methotrexat Accord 7.5 mg/0.15 ml	68244	A	L04AX03	2021-04-26
Midazolam Accord 5 mg/5 mL	66718	B	N05CD08	2018-07-24
Midazolam Accord 5 mg/5 ml	68432	B	N05CD08	2021-12-23
Nilotinib Accord 50 mg	70178	A	L01EA03	2025-07-28
Ondansetron Accord 4 mg/2 ml	66785	B	A04AA01	2018-12-07
Orgovyx 120 mg	69150	A	L02BX04	2023-11-17
Osvyrti 60 mg/1.0 ml	70101	B	M05BX04	2026-04-30
Oxaliplatin Accord 50 mg/10 ml	67140	A	L01XA03	2019-07-18
Paclitaxel Accord 30 mg/5 ml	66853	A	L01CD01	2019-09-25

Frequently asked questions

How many medicines does Accord Healthcare AG have authorised in Switzerland?

Accord Healthcare AG is recorded by Swissmedic as the authorisation holder for 65 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.

Where is Accord Healthcare AG based?

The Swiss location recorded for Accord Healthcare AG is Bottmingen, Basel-Landschaft.

Is Accord Healthcare AG a Swissmedic authorisation holder?

Yes. Accord Healthcare AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.

Sources

Last updated: 17 September 2026

Data from the Swissmedic list of authorised medicinal products as of 1 September 2026. Location, sector and website added by our own research.

About the operator

Swiss Pharma Partners

Public sources · Independent directory · Eight language versions

The Swiss Pharma Partners is an independent service and is neither affiliated with nor authorised by Swissmedic or the Federal Office of Public Health (FOPH).